Invention Grant
- Patent Title: Modulators of cystic fibrosis transmembrane conductance regulator
- Patent Title (中): 囊性纤维化跨膜电导调节剂的调节剂
-
Application No.: US13178677Application Date: 2011-07-08
-
Publication No.: US08586615B2Publication Date: 2013-11-19
- Inventor: Sarah Hadida-Ruah , Frederick Van Goor , Mark Miller , Jason McCartney , Jinglan Zhou , Vijayalaksmi Arumugam
- Applicant: Sarah Hadida-Ruah , Frederick Van Goor , Mark Miller , Jason McCartney , Jinglan Zhou , Vijayalaksmi Arumugam
- Applicant Address: US MA Cambridge
- Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee Address: US MA Cambridge
- Agent Michael J. DiVerdi
- Main IPC: A61K31/425
- IPC: A61K31/425 ; C07D277/00
Abstract:
The present invention relates to modulators of cystic fibrosis Transmembrane Conductance Regulator (“CFTR”), compositions thereof, and methods therewith. The present invention also relates to methods of treating CFTR mediated diseases using such modulators.
Public/Granted literature
- US20120010257A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Public/Granted day:2012-01-12
Information query
